AbbVie vs Johnson & Johnson: revenue, profit, margins and growth compared
AbbVie brought in $61.2B of revenue in fiscal 2025, Johnson & Johnson $94.2B in fiscal 2025. Revenue changed by +8.6% at AbbVie and +6.0% at Johnson & Johnson on the year before, so AbbVie grew faster. AbbVie kept 6.9% of its revenue as net profit, Johnson & Johnson 28.5%. Free cash flow was $17.8B at AbbVie and $19.7B at Johnson & Johnson.
Fiscal years as each company reports them; the two may end in different months.
Questions about AbbVie and Johnson & Johnson
Which is bigger by revenue, AbbVie or Johnson & Johnson?
Johnson & Johnson is bigger by revenue: $94.2B in fiscal 2025, against $61.2B for AbbVie in fiscal 2025.
Which keeps more of its revenue as profit, AbbVie or Johnson & Johnson?
AbbVie had a net margin of 6.9% in fiscal 2025; Johnson & Johnson had 28.5% in fiscal 2025.
Which grew revenue faster, AbbVie or Johnson & Johnson?
In their latest fiscal years revenue changed by +8.6% at AbbVie and +6.0% at Johnson & Johnson.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.